Mukka Proteins Limited has informed the Exchange regarding a press release dated December 06, 2025, titled "Mukka Proteins JV awarded First-of-its-Kind order of ₹474.89 crore for scientific treatment of legacy leachate".
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mukka Proteins Limited has shared a press release about its joint venture being awarded a first-of-its-kind order worth ₹474.89 crore. The order is for the scientific treatment of legacy leachate, which is liquid waste that seeps from old dumping sites. The project is a notable new business area for the company, which is primarily known for fish and protein-based products. Being a JV win, the order value will flow into the company through its share in the joint venture, not directly to Mukka Proteins.
This is a sizeable contract that diversifies Mukka Proteins into environmental waste management and could meaningfully boost future earnings through its JV stake. Investors may view it positively as it opens a new revenue stream, though execution risks remain typical for first-of-its-kind projects.